Return to homepagePandemic Pact

COVID-19 case analysis and identification of risk groups

Grant number: RITA1 / 02-120

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2022

  • Known Financial Commitments (USD)

    $39,316.06

  • Funder

    Estonian Research Council

  • Principal Investigator

    Lili Azin Milani

  • Research Location

    Estonia

  • Lead Research Institution

    University of Tartu, Institute of Genomics, University of Tartu

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The whole world is facing an existential health crisis: a novel disease, COVID-19, caused by the coronavirus SARS-CoV-2. Health systems have no previous experience in the treatment and prevention of disease / long-term consequences. The aim of the study is a systematic analysis of SARS-Cov-2 morbidity, disease severity, immune response and health consequences of infection in Estonia, which enables informed decisions in future outbreaks and develops the use of health data for medical decision support, public health monitoring, health planning and justification analysis. The study team includes physicians, epidemiologists, public health researchers, virologists, and computer scientists. We consider it important that the project is linked to the international COVID-19 research community and that Estonian data be brought to a standard format (OMOP),